The Clinical Outcome of FLAG Chemotherapy without Idarubicin in Patients with Relapsed or Refractory Acute Myeloid Leukemia

A refractory and resistant disease to conventional induction chemotherapy and relapsed disease are considered as the most important adverse prognostic factors for acute myeloid leukemia (AML). Sixty-one patients (median age, 33.6 yr) with relapsed or refractory AML were treated with the FLAG regimen...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Lee, Se Ryeon, Yang, Deok Hwan, Ahn, Jae Sook, Kim, Yeo Kyeoung, Lee, Je Jung, Choi, Young Jin, Shin, Ho Jin, Chung, Joo Seop, Cho, Yoon Young, Chae, Yee Soo, Kim, Jong Gwang, Sohn, Sang Kyun, Kim, Hyeoung Joon
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Academy of Medical Sciences 2009
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2698199/
https://ncbi.nlm.nih.gov/pubmed/19543516
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3346/jkms.2009.24.3.498
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados